<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=forest+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss"><channel><title>forest pharma - BingNews</title><link>http://www.bing.com/news/search?q=forest+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>forest pharma</title><link>http://www.bing.com/news/search?q=forest+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Forest Laboratories Responds to Icahn Filing</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fforest-laboratories-responds-to-icahn-filing&amp;c=15374064411208181958&amp;mkt=en-us</link><description>Forest Laboratories, Inc.Frank J. Murdolo, 1-212-224-6714Vice President - Investor RelationsorSard Verbinnen &amp; CoHugh Burns/Renee Soto/Lesley Bogdanow1-212-687-8080orMacKenzie PartnersDan Burch, 1-212 ...</description><pubDate>Mon, 30 Jul 2012 14:07:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Forest Laboratories to Acquire Furiex Pharmaceuticals for $1.1 Billion in Cash to Build on a Leading Position in Gastroenterology (GI)</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fforest-laboratories-to-acquire-furiex-pharmaceuticals-for-1-1-billion-cash-to-build-on-a&amp;c=11097568948105118356&amp;mkt=en-us</link><description>NEW YORK &amp; MORRISVILLE, N.C.--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced that Forest has entered into a definitive agreement ...</description><pubDate>Mon, 28 Apr 2014 00:42:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Forest Labs to Acquire Furiex Pharma a deal potentially worth $1.46 billion</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2fwww.benzinga.com%2fnews%2fearnings%2f14%2f04%2f4504607%2fforest-labs-to-acquire-furiex-pharma-a-deal-potentially-worth-1-46-billi&amp;c=13634196606480152207&amp;mkt=en-us</link><description>for up to $1.46 billion in cash, and rights. This deal also includes milestone payments to access Furiex's promising treatment for irritable bowel syndrome. “The acquisition of Furiex builds on our ...</description><pubDate>Mon, 28 Apr 2014 09:44:00 GMT</pubDate><News:Source>Benzinga.com</News:Source></item><item><title>Forest Labs to Buy Furiex Pharma in $1.5B Deal</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2fwww.foxbusiness.com%2ffeatures%2fforest-labs-to-buy-furiex-pharma-in-1-5b-deal&amp;c=10647267565678191095&amp;mkt=en-us</link><description>Forest Laboratories Inc said it would buy Furiex Pharmaceuticals Inc for up to $1.46 billion including milestone payments to access Furiex's promising treatment for irritable bowel syndrome. This is ...</description><pubDate>Mon, 28 Apr 2014 04:26:00 GMT</pubDate><News:Source>Fox Business</News:Source></item><item><title>Forest Laboratories Pays TransTech Pharma $50M Up Front in Diabetes Deal</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2fwww.genengnews.com%2ftopics%2fdrug-discovery%2fforest-laboratories-pays-transtech-pharma-50m-up-front-in-diabetes-deal%2f&amp;c=8763338199277149641&amp;mkt=en-us</link><description>Agreement covers liver-selective glucokinase activators and is valued at up to $1.105 billion. Forest Laboratories is paying TransTech Pharma $50 million in a collaboration related to the former’s ...</description><pubDate>Mon, 07 Jun 2010 17:00:00 GMT</pubDate><News:Source>GEN</News:Source></item><item><title>Canadian pharma company seeks $3M PILOT for Forest Lab sites</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a0f604b5e0e480fa8b2c7ec26958514&amp;url=https%3a%2f%2flibn.com%2f2015%2f06%2f25%2fcanadian-pharma-company-seeks-3m-pilot-for-forest-lab-sites%2f&amp;c=14032600359686390186&amp;mkt=en-us</link><description>Ropack, a Montreal-based pharmaceutical company, seeks tax breaks of more than $3 million as it plans to purchase two Forest Laboratories’ facilities on Long Island. Ropack applied with the Suffolk ...</description><pubDate>Wed, 24 Jun 2015 17:00:00 GMT</pubDate><News:Source>Long Island Business News</News:Source></item></channel></rss>